Toni Weinschenk

6.4k total citations · 1 hit paper
50 papers, 3.2k citations indexed

About

Toni Weinschenk is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Toni Weinschenk has authored 50 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Immunology, 27 papers in Molecular Biology and 23 papers in Oncology. Recurrent topics in Toni Weinschenk's work include Immunotherapy and Immune Responses (33 papers), vaccines and immunoinformatics approaches (14 papers) and Monoclonal and Polyclonal Antibodies Research (14 papers). Toni Weinschenk is often cited by papers focused on Immunotherapy and Immune Responses (33 papers), vaccines and immunoinformatics approaches (14 papers) and Monoclonal and Polyclonal Antibodies Research (14 papers). Toni Weinschenk collaborates with scholars based in Germany, United States and United Kingdom. Toni Weinschenk's co-authors include Stefan Stevanović, Hans‐Georg Rammensee, Hermann J. Schluesener, Jens Fritsche, Steffen Walter, Martin Priemer, Michael Blank, Christian Franci, Lélia Delamarre and Mahesh Yadav and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Toni Weinschenk

47 papers receiving 3.1k citations

Hit Papers

Predicting immunogenic tumour mutations by combining mass... 2014 2026 2018 2022 2014 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Toni Weinschenk Germany 24 2.0k 1.6k 1.4k 299 250 50 3.2k
Valérie Dutoit Switzerland 35 2.2k 1.1× 1.2k 0.8× 1.2k 0.9× 198 0.7× 271 1.1× 83 3.3k
Sebastian Boegel Germany 13 1.8k 0.9× 1.1k 0.7× 1.5k 1.0× 282 0.9× 219 0.9× 24 2.5k
Vaios Karanikas Switzerland 25 2.7k 1.4× 1.3k 0.8× 2.4k 1.7× 431 1.4× 341 1.4× 52 4.1k
Gundram Jung Germany 31 1.7k 0.8× 871 0.6× 1.4k 1.0× 729 2.4× 193 0.8× 114 2.9k
Joost Neijssen Netherlands 17 1.5k 0.8× 1.3k 0.8× 1.8k 1.2× 685 2.3× 157 0.6× 19 3.3k
Roberta Mortarini Italy 40 2.9k 1.4× 2.1k 1.3× 2.0k 1.4× 341 1.1× 439 1.8× 100 4.9k
Ferenc A. Scheeren Netherlands 26 1.5k 0.8× 1.4k 0.9× 1.2k 0.8× 165 0.6× 596 2.4× 49 3.4k
Todd D. Armstrong United States 29 2.3k 1.1× 843 0.5× 2.0k 1.4× 149 0.5× 232 0.9× 54 3.3k
Ainhoa Arina United States 28 2.7k 1.4× 1.1k 0.7× 2.3k 1.6× 288 1.0× 363 1.5× 50 4.2k
Christian Franci United States 12 2.0k 1.0× 1.1k 0.7× 1.4k 1.0× 212 0.7× 163 0.7× 12 3.0k

Countries citing papers authored by Toni Weinschenk

Since Specialization
Citations

This map shows the geographic impact of Toni Weinschenk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toni Weinschenk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toni Weinschenk more than expected).

Fields of papers citing papers by Toni Weinschenk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Toni Weinschenk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toni Weinschenk. The network helps show where Toni Weinschenk may publish in the future.

Co-authorship network of co-authors of Toni Weinschenk

This figure shows the co-authorship network connecting the top 25 collaborators of Toni Weinschenk. A scholar is included among the top collaborators of Toni Weinschenk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Toni Weinschenk. Toni Weinschenk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fritsche, Jens, Daniel J. Kowalewski, Frederik Gwinner, et al.. (2021). Pitfalls in HLA Ligandomics—How to Catch a Li(e)gand. Molecular & Cellular Proteomics. 20. 100110–100110. 18 indexed citations
2.
Bunk, Sebastian, Martin Hofmann, Felix Unverdorben, et al.. (2019). Effective Targeting of PRAME-Positive Tumors with Bispecific T Cell-Engaging Receptor (TCER®) Molecules. Blood. 134(Supplement_1). 3368–3368. 7 indexed citations
3.
Tsimberidou, Apostolia M., Carsten Reinhardt, Hong Ma, et al.. (2018). Phase I adoptive cellular therapy trial with ex-vivo stimulated autologous CD8+ T-cells against multiple targets (ACTolog IMA101) in patients with relapsed and/or refractory solid cancers.. Journal of Clinical Oncology. 36(5_suppl). TPS77–TPS77.
4.
Fritsche, Jens, Barbara Rakitsch, Franziska Hoffgaard, et al.. (2018). Translating Immunopeptidomics to Immunotherapy‐Decision‐Making for Patient and Personalized Target Selection. PROTEOMICS. 18(12). e1700284–e1700284. 24 indexed citations
5.
Yadav, Mahesh, Suchit Jhunjhunwala, Qui Phung, et al.. (2014). Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing. Nature. 515(7528). 572–576. 881 indexed citations breakdown →
6.
Walter, Steffen, Toni Weinschenk, Carsten Reinhardt, & Harpreet Singh‐Jasuja. (2012). Single-dose cyclophosphamide synergizes with immune responses to the renal cell cancer vaccine IMA901. OncoImmunology. 2(1). e22246–e22246. 32 indexed citations
7.
Ugel, Stefano, Elisa Peranzoni, Giacomo Desantis, et al.. (2012). Immune Tolerance to Tumor Antigens Occurs in a Specialized Environment of the Spleen. Cell Reports. 2(3). 628–639. 175 indexed citations
8.
Dutoit, Valérie, Christel Herold‐Mende, Norbert Hilf, et al.. (2012). Exploiting the glioblastoma peptidome to discover novel tumour-associated antigens for immunotherapy. Brain. 135(4). 1042–1054. 146 indexed citations
9.
Waldhauer, Inja, Friederike Gieseke, Toni Weinschenk, et al.. (2008). Tumor-Associated MICA Is Shed by ADAM Proteases. Cancer Research. 68(15). 6368–6376. 296 indexed citations
10.
Grünebach, Frank, Katharina M. Brauer, Maik Häntschel, et al.. (2007). Identification and Characterization of T-Cell Epitopes Deduced from RGS5, a Novel Broadly Expressed Tumor Antigen. Clinical Cancer Research. 13(11). 3347–3355. 38 indexed citations
11.
Krämer, Björn, Oliver Schoor, Tobias Krüger, et al.. (2005). MAGED4 – expression in renal cell carcinoma and identification of an HLA-A*25-restricted MHC class I ligand from solid tumor tissue. Cancer Biology & Therapy. 4(9). 943–948. 27 indexed citations
12.
Zhang, Zhiren, Toni Weinschenk, Ke‐Tai Guo, & Hermann J. Schluesener. (2005). siRNA binding proteins of microglial cells: PKR is an unanticipated ligand. Journal of Cellular Biochemistry. 97(6). 1217–1229. 29 indexed citations
13.
Zhang, Zhiren, Toni Weinschenk, & Hermann J. Schluesener. (2005). Uptake, cellular distribution and novel cellular binding proteins of immunostimulatory CpG oligodeoxynucleotides in glioblastoma cells. Molecular and Cellular Biochemistry. 272(1-2). 35–46. 9 indexed citations
14.
Krüger, Tobias, Oliver Schoor, Claudia Lemmel, et al.. (2004). Lessons to be learned from primary renal cell carcinomas: novel tumor antigens and HLA ligands for immunotherapy. Cancer Immunology Immunotherapy. 54(9). 826–836. 53 indexed citations
15.
Probst, Jochen, Stefan Tenzer, Toni Weinschenk, et al.. (2004). A conserved sequence in the mouse variable T cell receptor α recombination signal sequence 23‐bp spacer can affect recombination. European Journal of Immunology. 34(8). 2179–2190. 3 indexed citations
16.
Weinschenk, Toni, Thomas Kratt, Tobias Heck, et al.. (2004). CD8+ T-cell response against MUC1-derived peptides in gastrointestinal cancer survivors. Cancer Immunology Immunotherapy. 54(8). 750–758. 8 indexed citations
17.
Deininger, M., Toni Weinschenk, Richard Meyermann, & Hermann J. Schluesener. (2003). The allograft inflammatory factor‐1 in Creutzfeldt–Jakob disease brains. Neuropathology and Applied Neurobiology. 29(4). 389–399. 17 indexed citations
18.
Deininger, Martin H., Toni Weinschenk, Matthias Morgalla, Richard Meyermann, & Hermann J. Schluesener. (2002). Release of regulators of angiogenesis following Hypocrellin-A and -B photodynamic therapy of human brain tumor cells. Biochemical and Biophysical Research Communications. 298(4). 520–530. 37 indexed citations
19.
Blank, Michael, Toni Weinschenk, Martin Priemer, & Hermann J. Schluesener. (2001). Systematic Evolution of a DNA Aptamer Binding to Rat Brain Tumor Microvessels. Journal of Biological Chemistry. 276(19). 16464–16468. 255 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026